🚨 FDA Peptide Panel Update 🚨 for $HIMS holders The new FDA peptide advisory panel looks meaningfully more favorable to compounded peptides than expected. My rough tally: • 9 pro-access • 6 neutral/persuadable • 4 likely against Not everyone votes on every peptide, but

HIMS-14.20%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned